Japan Acute Respiratory Distress Syndrome Market Insight
Published: 22 May 2026 | Report Format: Electronic (PDF)
Japan ’s acute respiratory distress syndrome market is actually seeing meaningful growth at a 8.68% CAGR, partially because severe respiratory infections are becoming more common, plus pneumonia and sepsis keep showing up more often. Japan Acute Respiratory Distress
Japan Acute Respiratory Distress Syndrome Market Insights Forecasts to 2035
- The Japan Acute Respiratory Distress Syndrome Market Size Was Estimated at USD 766.94 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.68% from 2025 to 2035
- The Japan Acute Respiratory Distress Syndrome Market Size is Expected to Reach USD 1763.77 Million by 2035
Notable Insights for Japan Acute Respiratory Distress Syndrome Market
- Looking at the treatment type side of things, mechanical ventilation systems were roughly 42-44% of the Japan acute respiratory distress syndrome market in 2025, since ICU admissions are going up, plus more severe respiratory complications showing up, and also because hospitals are adopting newer respiratory support technologies, kinda faster than before.
- For end user breakdown, hospitals along with intensive care units made up around 68-70% of the Japan acute respiratory distress syndrome market in 2025. This is commonly linked to higher need for emergency breathing care, continuous critical patient monitoring, and specialized pulmonary treatment services that are not exactly “standard” in every setting.
- The Ministry of Health, Labour and Welfare (MHLW) Japan keeps backing critical care infrastructure modernization plus respiratory disease management programs, and that overall helps explain why advanced ARDS treatment technologies get taken up across Japan.
Download the eBook (ToC)
- More spending on ECMO systems, AI driven patient monitoring platforms, non-invasive respiratory support devices and pulmonary rehabilitation technologies are expected to open up pretty attractive growth chances for companies working in Japan, especially those that can scale deployment without too much friction.
What Makes Decisions Advisors Research Unique?
- Critical Respiratory Care Ecosystem Assessment and Pulmonary Treatment Trend Analysis
Decisions Advisors provides detailed analysis of intensive respiratory care technologies, pulmonary treatment advancements, ICU modernization trends, and critical patient management innovations influencing the Japan acute respiratory distress syndrome industry.
- Advanced Respiratory Therapy Forecasting and Critical Care Evaluation Framework
Our research methodology integrates expert interviews, hospital benchmarking, respiratory treatment analysis, and proprietary forecasting models to deliver accurate market intelligence for Japan’s evolving ARDS treatment sector.
- Intensive Care Technology Competition and Pulmonary Support Opportunity Mapping
We evaluate competitive positioning, ventilatory support advancements, ECMO technology developments, AI-powered patient monitoring trends, and respiratory rehabilitation innovations shaping investment opportunities across the Japan acute respiratory distress syndrome market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Acute Respiratory Distress Syndrome market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Japan Acute Respiratory Distress Syndrome Market
- Getinge AB
- Medtronic plc
- Koninklijke Philips N.V.
- Dragerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare Corporation Limited
- Hamilton Medical AG
- GE HealthCare Technologies Inc.
- Nihon Kohden Corporation
- Teleflex Incorporated
- ResMed Inc.
- Others
Recent Developments:
- In September 2025, Nihon Kohden Corporation expanded its advanced respiratory monitoring and critical care solutions portfolio across Japan to strengthen intensive pulmonary care management and improve ARDS patient treatment outcomes.
Market Segmentation:
Japan Acute Respiratory Distress Syndrome Market, By Treatment Type
- Mechanical Ventilation
- Extracorporeal Membrane Oxygenation (ECMO)
- Oxygen Therapy
- Drug Therapy
- Others
Japan Acute Respiratory Distress Syndrome Market, By Diagnosis
- Imaging Tests
- Blood Tests
- Pulmonary Function Tests
- Others
Japan Acute Respiratory Distress Syndrome Market, By End User
- Hospitals
- Intensive Care Units
- Specialty Clinics
- Ambulatory Care Centers
- Others
Expert Views:
Japan’s acute respiratory distress syndrome market is likely to see pretty notable growth in the next years, mainly because the prevalence of severe respiratory disorders keeps going up, ICU admissions rise, and there is more healthcare investment in critical care infrastructure. At the same time, improvements in ventilatory support systems, ECMO technologies, and AI-based respiratory monitoring platforms are expected to push that growth forward across Japan. There’s also a growing focus on pulmonary rehabilitation programs, emergency healthcare readiness, and next generation intensive care technologies, which should hand out solid chances for market players active in the Japan acute respiratory distress syndrome industry.
Author: Sanket and Pranali By Spherical Insights and Consulting